Translational Research in Malignancies Members
The Translational Research in Malignancies (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Choi, Jacob
Assistant Professor
Bio
I am a clinical investigator specializing in the management of melanoma and other skin cancers. My primary research focus is to identify and develop more effective therapeutic approaches for advanced ... [more]
de Viveiros, Pedro
Assistant Professor
Bio
I am an Assistant Professor of Medicine in the Northwestern University Feinberg School of Medicine. As a physician-scientist and oncologist, my research is centered on advancing the treatment of rare ... [more]
Dinner, Shira N
Associate Professor
Bio
Dr. Dinner is a clinical researcher with an interest in novel molecularly targeted therapies for leukemias, in particular acute lymphoblastic leukemia (ALL). Development of future clinical t... [more]
Dixit, Karan S
Assistant Professor
Bio
My research interests focus on primary brain tumors, specifically low grade gliomas, CNS lymphoma, and high grade gliomas. I also have an interest in integrating neuropsychological testing with advanc... [more]
Dmello, Crismita
Assistant Professor
Bio
My central hypothesis is that glioma cell-specific Chek2-YBX1/3 interaction transcriptionally reprograms the glioma cells to escape the CD8 T cell mediated killing.
Ecker, Brett
Assistant Professor
Bio
I have broad interest in clinical trial design and identification of novel clinicogenomic biomarkers of treatment response in digestive tract malignancies. I am currently funded to study translational... [more]
Eckerdt, Frank
Research Associate Professor
Bio
The goal of my research is to define and target signaling networks promoting resistance mechanisms in cancer stem cells (CSCs) of the brain. Brain cancers are heterogeneous tumors, exhibitin... [more]
Eklund, Elizabeth A.
Professor
Bio
The focus of my laboratory is to understand the key events in normal myelopoiesis and how leukemia-associated mutations derange these processes during leukemogenesis.
Godley, Lucy
Professor
Bio
The Godley laboratory studies the molecular pathways that drive hematopoietic malignancies, with a focus on understanding how germline predisposition alleles contribute to individual and family risk a... [more]
Gordon, Andrew
Assistant Professor
Bio
As an Interventional Radiologist and Physician-Scientist, I enjoy offering patients minimally invasive options to help diagnose or treat diseases such as cancer. My research interests include developm... [more]